Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline in primary ciliary dyskinesia pilot study
NL-OMON40843Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in primary ciliary dyskinesia (PCD) and Kartagener syndrome comparing Hypertonic saline 7% with Isotonic saline placebo (2 arms). Primary endpoint: Change in St. George's Respiratory Questionnaire score. Started Sep 2013; status: active, not recruiting.
02
Drugs
hypertonic salineisotonic saline
03
Conditions
primary ciliary dyskinesia (PCD)Kartagener syndrome
Beyond the preview
Go deeper on NL-OMON40843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40843.